Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas of Bipartisan Consensus Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday ahead of three legislative proceedings on drug pricing proposals scheduled for Thursday. The U.S. House Committee on Ways and Means is slated to hold a […]
Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of Agreement to Hold Big Pharma Accountable and Lower Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday ahead of a U.S. House Committee on Energy and Commerce Subcommittee on Health hearing Wednesday titled “Making Prescription Drugs More […]
Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from Both Sides of the Aisle Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the release of details of a drug pricing plan circulated by U.S. House Speaker Nancy Pelosi (D-CA). “The plan unveiled by leaders in the […]
Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes, Saved Program $8 Billion on Drug Costs Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today following the release of a new report from the U.S. Department of Health & Human Services (HHS) Office of Inspector General on rebates […]
Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs, AHIP Finds Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today following the release of a new report from America’s Health Insurance Plans (AHIP) that found Big Pharma manipulated The Orphan Drug Act in order to raise the prices of […]
Applauds HHS For Appealing Ruling Against List Price Transparency Measure Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today after the U.S. Department of Health and Human services appealed a federal ruling blocking the implementation of a measure to require drug makers to disclose list prices in direct-to-consumer (DTC) advertising. […]
Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums Down A new report from the Government Accountability Office (GAO) undermines a common refrain in Big Pharma’s blame game targeting pharmacy benefit managers (PBMs) and rebates. In an effort to distract from their own price-gouging and anti-competitive behavior, Big Pharma frequently […]
Commends Bipartisan Collaboration on Several Market-Based Solutions, Cautions Committee Leaders Against Revival of Misguided Rebate Rule Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday commending members of the U.S. Senate Committee on Finance for advancing a drug pricing package that contains a number of measures that will hold Big […]
Looks Forward to Working With Senate Finance Members to Hold Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday commending Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) for moving ahead with a U.S. Senate Committee on Finance package to lower prescription drug prices. On […]
Drug Makers’ Shares Hit ‘All-Time High’ Off Of Price-Gouging American Patients Today Big Pharma giant Novartis announced better-than-expected earnings for the second quarter of 2019. The brand name drug maker reported $11.76 billion in sales in Q2 – up from $11.34 billion last year – beating analysts’ expectations. As a result, the company raised its […]